STAT3 regulates miR93-mediated apoptosis through inhibiting DAPK1 in renal cell carcinoma

Yang Du1, Chuize Kong2

  • 1Department of Urology, First Hospital of China Medical University, 110001, Shenyang, China.

Cancer Gene Therapy
|November 24, 2020
PubMed

Insights

Signal transducer and activator of transcription 3 (STAT3) promotes renal cell carcinoma (RCC) by upregulating miR-93, which inhibits DAPK1. This STAT3-miR93-DAPK1 pathway offers a potential therapeutic target for RCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Signal transducer and activator of transcription 3 (STAT3) is crucial in regulating inflammatory responses, cell survival, proliferation, and angiogenesis.
  • Aberrant STAT3 activation is implicated in various cancers, including renal cell carcinoma (RCC).
  • STAT3 signaling pathways are complex and involve multiple feedback loops.

Purpose of the Study:

  • To investigate the role of miR-93-3p in renal cell carcinoma (RCC).
  • To elucidate the regulatory relationship between STAT3, miR-93, and death-associated protein kinase 1 (DAPK1) in RCC.
  • To identify a potential therapeutic pathway for RCC.

Main Methods:

  • Investigated the function of miR-93-3p in RCC cell proliferation and apoptosis.
  • Analyzed the transcriptional regulation of miR-93 by STAT3.
  • Examined the inhibitory effect of miR-93 on DAPK1 expression.
  • Assessed the impact of DAPK1 on STAT3 nuclear translocation.

Main Results:

  • miR-93-3p enhances RCC cell proliferation and suppresses apoptosis, indicating an oncogenic role.
  • STAT3 directly regulates miR-93 transcription.
  • miR-93 inhibits DAPK1 protein expression, and STAT3 further suppresses DAPK1 at the RNA level.
  • Overexpressed DAPK1 inhibits activated STAT3 nuclear entry.

Conclusions:

  • A novel STAT3-miR93-DAPK1 signaling pathway was identified in RCC.
  • This pathway is continuously activated and contributes to RCC progression.
  • The STAT3-miR93-DAPK1 axis represents a potential therapeutic target for RCC treatment.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.3K